| HORIZON | TRADES | WIN RATE | INSIDER RETURN | SPY RETURN | MEAN EXCESS | MEDIAN EXCESS | T-STAT |
|---|---|---|---|---|---|---|---|
| 7d | 1 | +100.00% | -23.08% | +1.08% | -24.16% | -24.16% | — |
| 14d | 1 | +100.00% | -57.69% | +2.80% | -60.49% | -60.49% | — |
| 30d | 1 | +100.00% | -42.31% | — | — | — | — |
| 60d | 1 | +100.00% | -34.62% | +6.06% | -40.67% | -40.67% | — |
| 90d | 1(1 pending) | — | — | — | — | — | — |
| 180d | 1(1 pending) | — | — | — | — | — | — |
| 1y | 1(1 pending) | — | — | — | — | — | — |
| 2y | 1(1 pending) | — | — | — | — | — | — |
| COMPANY | TYPE | SHARES | PRICE | VALUE | HELD AFTER | TRADE DATE | FILED | DETAILS |
|---|---|---|---|---|---|---|---|---|
| SGMO SANGAMO THERAPEUTICS, INC | SALE SVP-CHIEF DEVELOPMENT OFFICER | 345,942 | $0.26 | $89.2K | 332,769 | Apr 21, 2026 | Apr 23, 2026 ↗ | View → |
| SGMO SANGAMO THERAPEUTICS, INC | PURCHASEGRANT Stock grant | 800,000 | — | — | 800,000 | Apr 1, 2026 | Apr 3, 2026 ↗ | View → |
| SGMO SANGAMO THERAPEUTICS, INC | SALE SVP-CHIEF DEVELOPMENT OFFICER | 12,354 | $0.47 | $5.8K | 678,711 | Feb 25, 2026 | Feb 26, 2026 ↗ | View → |
| SGMO SANGAMO THERAPEUTICS, INC | SALE SVP-CHIEF DEVELOPMENT OFFICER | 2,063 | $0.47 | $975 | 691,065 | Feb 24, 2026 | Feb 26, 2026 ↗ | View → |
| SGMO SANGAMO THERAPEUTICS, INC | SALE SVP-CHIEF DEVELOPMENT OFFICER | 36,676 | $0.40 | $14.6K | 693,128 | Jan 22, 2026 | Jan 26, 2026 ↗ | View → |
| SGMO SANGAMO THERAPEUTICS, INC | SALE SVP-CHIEF DEVELOPMENT OFFICER | 2,544 | $0.42 | $1.1K | 719,804 | Nov 24, 2025 | Nov 26, 2025 ↗ | View → |
| SGMO SANGAMO THERAPEUTICS, INC | SALE SVP-CHIEF DEVELOPMENT OFFICER | 43,741 | $0.66 | $28.9K | 722,348 | Oct 22, 2025 | Oct 24, 2025 ↗ | View → |
| SGMO SANGAMO THERAPEUTICS, INC | SALE SVP-CHIEF DEVELOPMENT OFFICER | 1,792 | $0.59 | $1.1K | 766,089 | Aug 24, 2025 | Aug 26, 2025 ↗ | View → |
| SGMO SANGAMO THERAPEUTICS, INC | SALE SVP-CHIEF DEVELOPMENT OFFICER | 31,866 | $0.48 | $15.3K | 767,881 | Jul 22, 2025 | Jul 24, 2025 ↗ | View → |
| SGMO SANGAMO THERAPEUTICS, INC | SALE SVP-CHIEF DEVELOPMENT OFFICER | 1,792 | $0.47 | $848 | 799,747 | May 24, 2025 | May 28, 2025 ↗ | View → |
| SGMO SANGAMO THERAPEUTICS, INC | SALE SVP-CHIEF DEVELOPMENT OFFICER | 31,866 | $0.78 | $24.7K | 801,539 | Apr 22, 2025 | Apr 24, 2025 ↗ | View → |
| SGMO SANGAMO THERAPEUTICS, INC | PURCHASEGRANT Stock grant | 560,000 | — | — | 560,000 | Feb 25, 2025 | Feb 26, 2025 ↗ | View → |
| SGMO SANGAMO THERAPEUTICS, INC | PURCHASEGRANT Stock grant | 120,000 | — | — | 833,405 | Feb 25, 2025 | Feb 26, 2025 ↗ | View → |
| SGMO SANGAMO THERAPEUTICS, INC | SALE SVP-CHIEF DEVELOPMENT OFFICER | 1,513 | $0.96 | $1.4K | 713,405 | Feb 25, 2025 | Feb 26, 2025 ↗ | View → |
| SGMO SANGAMO THERAPEUTICS, INC | SALE SVP-CHIEF DEVELOPMENT OFFICER | 1,792 | $1.00 | $1.8K | 714,918 | Feb 24, 2025 | Feb 26, 2025 ↗ | View → |
| SGMO SANGAMO THERAPEUTICS, INC | SALE SVP-CHIEF DEVELOPMENT OFFICER | 129,593 | $1.15 | $149.0K | 716,710 | Jan 22, 2025 | Jan 24, 2025 ↗ | View → |
| SGMO SANGAMO THERAPEUTICS, INC | SALE SVP-CHIEF DEVELOPMENT OFFICER | 1,508 | $1.94 | $2.9K | 841,303 | Nov 25, 2024 | Nov 26, 2024 ↗ | View → |
| SGMO SANGAMO THERAPEUTICS, INC | SALE SVP-CHIEF DEVELOPMENT OFFICER | 1,787 | $1.88 | $3.4K | 842,811 | Nov 24, 2024 | Nov 26, 2024 ↗ | View → |
| SGMO SANGAMO THERAPEUTICS, INC | SALE SVP-CHIEF DEVELOPMENT OFFICER | 1,508 | $0.86 | $1.3K | 844,598 | Aug 25, 2024 | Aug 27, 2024 ↗ | View → |
| SGMO SANGAMO THERAPEUTICS, INC | SALE SVP-CHIEF DEVELOPMENT OFFICER | 1,787 | $0.86 | $1.5K | 846,106 | Aug 24, 2024 | Aug 27, 2024 ↗ | View → |
| SGMO SANGAMO THERAPEUTICS, INC | SALE SVP-CHIEF DEVELOPMENT OFFICER | 1,508 | $0.60 | $905 | 842,893 | May 25, 2024 | May 29, 2024 ↗ | View → |
| SGMO SANGAMO THERAPEUTICS, INC | SALE SVP-CHIEF DEVELOPMENT OFFICER | 1,787 | $0.60 | $1.1K | 844,401 | May 24, 2024 | May 29, 2024 ↗ | View → |
| SGMO SANGAMO THERAPEUTICS, INC | SALE SVP-CHIEF DEVELOPMENT OFFICER | 5,010 | $1.13 | $5.7K | 846,188 | Feb 25, 2024 | Feb 27, 2024 ↗ | View → |
| SGMO SANGAMO THERAPEUTICS, INC | SALE SVP-CHIEF DEVELOPMENT OFFICER | 5,474 | $1.13 | $6.2K | 851,198 | Feb 24, 2024 | Feb 27, 2024 ↗ | View → |
| SGMO SANGAMO THERAPEUTICS, INC | PURCHASEGRANT Stock grant | 712,500 | — | — | 856,672 | Jan 22, 2024 | Jan 24, 2024 ↗ | View → |
| SGMO SANGAMO THERAPEUTICS, INC | SALE SVP-Chief Development Officer | 1,462 | $0.38 | $559 | 139,172 | Nov 25, 2023 | Nov 28, 2023 ↗ | View → |
| SGMO SANGAMO THERAPEUTICS, INC | SALE SVP-Chief Development Officer | 1,462 | $0.77 | $1.1K | 140,634 | Aug 25, 2023 | Aug 29, 2023 ↗ | View → |
| SGMO SANGAMO THERAPEUTICS, INC | SALE SVP-Chief Development Officer | 1,462 | $1.33 | $1.9K | 137,096 | May 25, 2023 | May 30, 2023 ↗ | View → |
| SGMO SANGAMO THERAPEUTICS, INC | SALE SVP-Chief Development Officer | 9,834 | $2.66 | $26.2K | 138,558 | Feb 25, 2023 | Mar 6, 2023 ↗ | View → |
| SGMO SANGAMO THERAPEUTICS, INC | PURCHASEGRANT Stock grant | 53,438 | — | — | 148,392 | Feb 24, 2023 | Mar 6, 2023 ↗ | View → |
| SGMO SANGAMO THERAPEUTICS, INC | PURCHASEGRANT Stock grant | 249,375 | — | — | 249,375 | Feb 24, 2023 | Mar 6, 2023 ↗ | View → |